Pliant Therapeutics logo

Pliant Therapeutics share price today

(PLRX)

Pliant Therapeutics share price is $13.18 & ₹1,130.98 as on 7 Jan 2025, 2.30 'hrs' IST

$13.18

-0.35

(-2.59%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Pliant Therapeutics share price in Dollar and Rupees. Guide to invest in Pliant Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pliant Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Pliant Therapeutics share price movements

  • Today's Low: $13.02
    Today's High: $13.67

    Day's Volatility :4.75%

  • 52 Weeks Low: $10.22
    52 Weeks High: $19.62

    52 Weeks Volatility :47.91%

Pliant Therapeutics Returns

PeriodPliant Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
20.37%
-8.4%
0.0%
6 Months
22.55%
-3.8%
0.0%
1 Year
-30.93%
-0.1%
0.0%
3 Years
14.76%
2.9%
-19.8%

Pliant Therapeutics Key Statistics

in dollars & INR

Previous Close
$13.53
Open
$13.55
Today's High
$13.67
Today's Low
$13.02
Market Capitalization
$801.4M
Today's Volume
$254.1K
52 Week High
$19.62
52 Week Low
$10.22
Revenue TTM
$0.0
EBITDA
$-220.0M
Earnings Per Share (EPS)
$-3.35
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-47.52%

How to invest in Pliant Therapeutics from India?

It is very easy for Indian residents to invest directly in Pliant Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pliant Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pliant Therapeutics or PLRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pliant Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pliant Therapeutics shares which would translate to 0.065 fractional shares of Pliant Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pliant Therapeutics, in just a few clicks!

Returns in Pliant Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pliant Therapeutics investment value today

Current value as on today

₹70,502

Returns

₹29,498

(-29.5%)

Returns from Pliant Therapeutics Stock

₹32,721 (-32.72%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Pliant Therapeutics

23%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Pliant Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 23% more investors are searching Pliant Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Pliant Therapeutics

  • Deep Track Capital, LP

    9.81%

  • BlackRock Inc

    8.17%

  • T. Rowe Price Associates, Inc.

    7.95%

  • FMR Inc

    6.41%

  • Vanguard Group Inc

    5.80%

  • Redmile Group, LLC

    5.25%

Analyst Recommendation on Pliant Therapeutics

Buy

    95%Buy

    5%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Pliant Therapeutics(by analysts ranked 0 to 5 stars)

Based on 20 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
19
19
19
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Pliant Therapeutics

What analysts predicted

Upside of 204.87%

Current:

$13.18

Target:

$40.18

Insights on Pliant Therapeutics

  • Price Movement

    In the last 7 days, PLRX stock has moved up by 5.8%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 248.0K → 4.83M (in $), with an average increase of 94.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -41.10M → -57.76M (in $), with an average decrease of 12.2% per quarter
  • PLRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 47.9%
  • PLRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 52.0%

Pliant Therapeutics Technicals Summary

Sell

Neutral

Buy

Pliant Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Pliant Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pliant Therapeutics Inc
-8.89%
22.55%
-30.93%
14.76%
-36.48%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pliant Therapeutics Inc
NA
NA
NA
-3.63
-0.48
-0.28
NA
5.68
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pliant Therapeutics Inc
Buy
$801.4M
-36.48%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Pliant Therapeutics

pliant therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. by harnessing the therapeutic potential of integrin biology and tgf-β modulation, pliant aims to prevent or even reverse fibrosis to address the needs of many patients. the company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. pliant’s co-founders include world-renowned researchers from university of california, san francisco (ucsf), who bring broad experience in fibrosis biology and small molecule chemistry. together, the pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.
Organization
Pliant Therapeutics
Employees
166
CEO
Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Industry
Health Technology

Management People of Pliant Therapeutics

NameTitle
Dr. Bernard Coulie M.B.A., M.D., Ph.D.
President, CEO & Director
Dr. Keith Lamont Cummings M.B.A., M.D.
Chief Financial Officer
Mr. Mike Ouimette J.D.
General Counsel & Corporate Secretary
Mr. Johannes P. Hull
Chief Business Officer
Dr. Eric A. Lefebvre M.D.
Chief Medical Officer
Dr. Rik Derynck
Scientific Founder & Member of Scientific Advisory Board
Mr. Dean Sheppard M.D.
Scientific Founder & Member of Scientific Advisory Board
Mr. Bill DeGrado Ph.D.
Scientific Founder & Member of Scientific Advisory Board
Mr. Hal Chapman M.D.
Scientific Founder & Member of Scientific Advisory Board
Mr. Craig D. Muir
Interim Chief Technology Officer

Important FAQs about investing in Pliant Therapeutics from India :

What is Pliant Therapeutics share price today?

Pliant Therapeutics share price today stands at $13.18, Open: $13.55 ; Previous Close: $13.53 ; High: $13.67 ; Low: $13.02 ; 52 Week High: $19.62 ; 52 Week Low: $10.22. The stock opens at $13.55, after a previous close of $13.53. The stock reached a daily high of $13.67 and a low of $13.02, with a 52-week high of $19.62 and a 52-week low of $10.22.

Can Indians buy Pliant Therapeutics shares?

Yes, Indians can invest in the Pliant Therapeutics (PLRX) from India.

With INDmoney, you can buy Pliant Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pliant Therapeutics at zero transaction cost.

How can I buy Pliant Therapeutics shares from India?

It is very easy to buy Pliant Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pliant Therapeutics be purchased?

Yes, you can buy fractional shares of Pliant Therapeutics with INDmoney app.

What are the documents required to start investing in Pliant Therapeutics stocks?

To start investing in Pliant Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pliant Therapeutics

Today’s highest price of Pliant Therapeutics (PLRX) is $13.67.

Today’s lowest price of Pliant Therapeutics (PLRX) is $13.02.

What is today's market capitalisation of Pliant Therapeutics

Today's market capitalisation of Pliant Therapeutics PLRX is 801.4M

What is the 52 Week High and Low Range of Pliant Therapeutics

  • 52 Week High

    $19.62

  • 52 Week Low

    $10.22

What are the historical returns of Pliant Therapeutics?

  • 1 Month Returns

    -8.89%

  • 3 Months Returns

    22.55%

  • 1 Year Returns

    -30.93%

  • 5 Years Returns

    -36.48%

Who is the Chief Executive Officer (CEO) of Pliant Therapeutics

Dr. Bernard Coulie M.B.A., M.D., Ph.D. is the current Chief Executive Officer (CEO) of Pliant Therapeutics.